Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
What the Clinical Trial Data Shows for Retatrutide Phase 2 clinical trial results, published in the New England Journal of Medicine, demonstrated that retatrutide produced mean body weight reductions of 17.5% at the 4mg dose and 24.2% at the 12mg dose over 48 weeks in adults with obesity [8]
To unlock their potential for clinical applications, future studies may move beyond anticipated rewards to cover other reward facets
With over 100 million downloads, The Peter Attia Drive investigates everything from exercise and nutritional biochemistry to cardiovascular health, cancer, cognitive health, mental and emotional well-being, and beyond
Mix 4 g of powder in 200 ml of water (approximately 2 scoops), 30 minutes before physical activity.
PlexusDx sources exclusively from 503A compounding facilities operating under strict pharmaceutical regulations and state board oversight, ensuring quality control equivalent to mass-manufactured alternatives
If you are participating in a clinical trial or receiving retatrutide under specialist supervision, any decision to pause or stop treatment should be discussed with your study team or supervising clinician
